Further understanding of the mechanisms by which miRNA, PKLR, and pyruvate regulate HCV and HBV replication through ATP and other glycolytic intermediates may facilitate the development of strategies to prevent establishment of persistent infection for HCV, HBV, and possibly other viral infections. This evidence concerns the gene PKLR and viral infectious disease.